Leap Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (11)

Latest Posts

About This Stock More About This Stock
Week In Review: Shanghai's I-Mab Plans $100 Million NASDAQ IPO On January 16
Article By: ChinaBio® Today
Sunday, January 5, 2020 10:20 AM EST
I-Mab, a Phase III Shanghai immunoncology-autoimmune biopharma, announced the terms for its $100 million IPO on the NASDAQ exchange at a market value of $750 million. The company plans to offer 7.4 million shares between $12 and $15.
In this article: BGNE, LPTX
Read
Leap Therapeutics Announces Pricing Of $14 Million Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Friday, March 23, 2018 9:52 AM EST
Leap Therapeutics, Inc. today announced the pricing of an underwritten public offering of 1,866,667 shares of its common stock at a public offering price of $7.50 per share.
In this article: LPTX
Read
Incyte Rises After ASCO Abstracts, But Piper Urges Closer Look
Article By: The Fly
Wednesday, May 17, 2017 9:48 PM EST
The release of study abstracts for next month's ASCO conference drove significant moves tonight in drugmakers, but Piper Jaffray urged caution on the company's data, saying its "not sure what other investors are seeing that we aren't."
In this article: MRK, INCY, NLNK, AMGN, NKTR, CYTR, BLUE, LBIO, LPTX
Read

PARTNER HEADLINES

Latest Tweets for $LPTX

No tweets yet!